13F HOLDINGS REPORT
VR Adviser, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-014110
Total Value
$1.46B
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 8,493,321 | $384.7M | 26.40% |
| 2 | OCULAR THERAPEUTIX INC | OCUL | 12,762,462 | $109.0M | 7.48% |
| 3 | ENLIVEN THERAPEUTICS INC | ELVN | 4,026,331 | $90.6M | 6.22% |
| 4 | PRAXIS PRECISION MEDICINES I | PRAX | 989,985 | $76.2M | 5.23% |
| 5 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,882,709 | $74.4M | 5.11% |
| 6 | ORUKA THERAPEUTICS INC | ORKA | 3,285,620 | $63.7M | 4.37% |
| 7 | SPYRE THERAPEUTICS INC | SYRE | 2,685,448 | $62.5M | 4.29% |
| 8 | PHARVARIS N V | PHVS | 3,220,130 | $61.7M | 4.24% |
| 9 | KALVISTA PHARMACEUTICALS INC | KALV | 6,249,731 | $52.9M | 3.63% |
| 10 | DYNE THERAPEUTICS INC | DYN | 2,173,913 | $51.2M | 3.51% |
| 11 | COGENT BIOSCIENCES INC | COGT | 5,684,411 | $44.3M | 3.04% |
| 12 | ERASCA INC | ERAS | 16,216,216 | $40.7M | 2.79% |
| 13 | DIANTHUS THERAPEUTICS INC | DNTH | 1,744,373 | $38.0M | 2.61% |
| 14 | UPSTREAM BIO INC | UPB | 2,295,319 | $37.7M | 2.59% |
| 15 | ORIC PHARMACEUTICALS INC | ORIC | 4,394,527 | $35.5M | 2.43% |
| 16 | ENGENE HOLDINGS INC | ENGNW | 5,046,414 | $33.6M | 2.30% |
| 17 | MERUS N V | N5749R100 | 592,411 | $24.9M | 1.71% |
| 18 | ASTRIA THERAPEUTICS INC | 04635X102 | 2,457,348 | $22.0M | 1.51% |
| 19 | CIDARA THERAPEUTICS INC | 171757206 | 765,723 | $20.6M | 1.41% |
| 20 | CULLINAN THERAPEUTICS INC | CGEM | 1,379,965 | $16.8M | 1.15% |
| 21 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 2,952,371 | $16.4M | 1.13% |
| 22 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 1,609,569 | $16.2M | 1.11% |
| 23 | MERSANA THERAPEUTICS INC | 59045L106 | 10,257,790 | $14.7M | 1.01% |
| 24 | ABIVAX SA | AAVXF | 1,345,780 | $9.9M | 0.68% |
| 25 | AQUESTIVE THERAPEUTICS INC | AQST | 2,629,786 | $9.4M | 0.64% |
| 26 | APPLIED THERAPEUTICS INC | 03828A101 | 9,990,591 | $8.6M | 0.59% |
| 27 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 750,000 | $7.6M | 0.52% |
| 28 | TERNS PHARMACEUTICALS INC | TERN | 1,077,090 | $6.0M | 0.41% |
| 29 | TAYSHA GENE THERAPIES INC | TSHA | 3,225,180 | $5.6M | 0.38% |
| 30 | TREVI THERAPEUTICS INC | TRVI | 1,266,457 | $5.2M | 0.36% |
| 31 | ZURA BIO LTD | ZURA | 2,023,166 | $5.1M | 0.35% |
| 32 | CENTURY THERAPEUTICS INC | IPSC | 3,957,186 | $4.0M | 0.27% |
| 33 | CASI PHARMACEUTICALS INC | CASIF | 987,259 | $2.8M | 0.19% |
| 34 | TENAYA THERAPEUTICS INC | TNYA | 1,555,556 | $2.2M | 0.15% |
| 35 | TENAX THERAPEUTICS INC | TENX | 208,333 | $1.3M | 0.09% |
| 36 | GLYCOMIMETICS INC | 38000Q102 | 3,000,000 | $747,000 | 0.05% |
| 37 | INSTIL BIO INC | TIL | 33,177 | $633,349 | 0.04% |